WAT Medical proudly introduced HeadaTerm 2, an innovative wearable anti-migraine device, at the American Headache Society’s 66th Annual Scientific Meeting, held in San Diego, California. The device has recently received FDA approval for over-the-counter (OTC) use. This landmark achievement positions HeadaTerm 2 as one of the few non-drug medical devices available in the U.S. without